Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 5:5:15.
doi: 10.21037/tgh.2019.10.17. eCollection 2020.

Ablative therapies for hepatic and biliary tumors: endohepatology coming of age

Jinendra Satiya  1 , Ingrid Schwartz  2 , James H Tabibian  3   4 , Vivek Kumar  5 , Mohit Girotra  6
Affiliations
Review

Ablative therapies for hepatic and biliary tumors: endohepatology coming of age

Jinendra Satiya et al. Transl Gastroenterol Hepatol. .

Abstract

Ablative therapies refer to minimally invasive procedures performed to destroy abnormal tissue that may arise with many conditions, and can be achieved clinically using chemical, thermal, and other techniques. In this review article, we explore the different ablative therapies used in the management of hepatic and biliary malignancies, namely hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), with a particular focus on radiofrequency ablation (RFA) and photodynamic therapy (PDT) techniques.

Keywords: Ablative therapies; cholangiocarcinoma (CCA); hepatocellular carcinoma (HCC); photodynamic therapy (PDT); radiofrequency ablation (RFA).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Habib ERCP probe: single use 180 cm length, 8 Fr (2.6 mm) diameter, fits over 0.035" guidewire (picture used with permission from Boston Scientific, MA, USA). ERCP, endoscopic retrograde cholangiography.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Hansen PD, Cassera MA, Wolf RF. Ablative technologies for hepatocellular, cholangiocarcinoma, and metastatic colorectal cancer of the liver. Surg Oncol Clin N Am 2015;24:97-119. 10.1016/j.soc.2014.09.003 - DOI - PubMed
    1. Yu MA, Liang P, Yu XL, et al. Sonography-guided percutaneous microwave ablation of intrahepatic primary cholangiocarcinoma. Eur J Radiol 2011;80:548-52. 10.1016/j.ejrad.2011.01.014 - DOI - PubMed
    1. Chahal P, Baron T. Endoscopic palliation of cholangiocarcinoma. Curr Opin Gastroenterol 2006;22:551-60. 10.1097/01.mog.0000239872.12081.a4 - DOI - PubMed
    1. Lyu T, Wang X, Su Z, et al. Irreversible electroporation in primary and metastatic hepatic malignancies: A review. Medicine (Baltimore) 2017;96:e6386. 10.1097/MD.0000000000006386 - DOI - PMC - PubMed
    1. Shiina S, Tateishi R, Arano T, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-Year outcome and prognostic factors. Am J Gastroenterol 2012;107:569-77. 10.1038/ajg.2011.425 - DOI - PMC - PubMed